A complication of the infusaid pump: Duodenal atony reversed by urecholine

Allan W. Silberman; Eliot Rosenkranz; Christopher Kosakowski; Arun Chervu; Roy I. Sugasawara; Kenneth P. Ramming

doi:10.1002/jso.2930360312

A complication of the infusaid pump: Duodenal atony reversed by urecholine

Allan W. Silberman, Eliot Rosenkranz, Christopher Kosakowski, Arun Chervu, Roy I. Sugasawara, Kenneth P. Ramming

Research output: Contribution to journal › Article › peer-review

Abstract

The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.

Original language	English (US)
Pages (from-to)	210-214
Number of pages	5
Journal	Journal of surgical oncology
Volume	36
Issue number	3
DOIs	https://doi.org/10.1002/jso.2930360312
State	Published - Nov 1987
Externally published	Yes

Keywords

FUDR
Infusaid pump
liver
metastatic disease

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.2930360312

Fingerprint Dive into the research topics of 'A complication of the infusaid pump: Duodenal atony reversed by urecholine'. Together they form a unique fingerprint.

Cite this

@article{2689b2ac52ed459c92d80f96494921be,

title = "A complication of the infusaid pump: Duodenal atony reversed by urecholine",

abstract = "The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.",

keywords = "FUDR, Infusaid pump, liver, metastatic disease",

author = "Silberman, {Allan W.} and Eliot Rosenkranz and Christopher Kosakowski and Arun Chervu and Sugasawara, {Roy I.} and Ramming, {Kenneth P.}",

year = "1987",

month = nov,

doi = "10.1002/jso.2930360312",

language = "English (US)",

volume = "36",

pages = "210--214",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - A complication of the infusaid pump

T2 - Duodenal atony reversed by urecholine

AU - Silberman, Allan W.

AU - Rosenkranz, Eliot

AU - Kosakowski, Christopher

AU - Chervu, Arun

AU - Sugasawara, Roy I.

AU - Ramming, Kenneth P.

PY - 1987/11

Y1 - 1987/11

N2 - The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.

AB - The totally implantable infusion pump (Infusaid pump) for treating metastatic disease to the liver is a new treatment that is gaining widespread acceptance. However, as might be expected for any new major surgical procedure, there are increasing reports of complications. We report a complication in which duodenal atony was caused by the infusion of the chemotherapeutic agent (FUDR) into the stomach and duodenum. The atony was totally reversed by the subcutaneous administration of Urecholine.

KW - FUDR

KW - Infusaid pump

KW - liver

KW - metastatic disease

UR - http://www.scopus.com/inward/record.url?scp=0023575588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023575588&partnerID=8YFLogxK

U2 - 10.1002/jso.2930360312

DO - 10.1002/jso.2930360312

M3 - Article

C2 - 2960855

AN - SCOPUS:0023575588

VL - 36

SP - 210

EP - 214

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -